Entos pulls in $53m Series A

Entos, Inc, a creator of a cutting-edge platform combining AI-driven technology and automated synthetic development to design small-molecule therapeutics, has secured $53 million in Series A financing.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this